Risk of colorectal cancer for fecal immunochemistry test-positive, average-risk patients after a colonoscopy.

Takuji KawamuraShiho NakamuraDaiki SoneHiroaki SakaiKana AmamiyaNaonori InoueNaokuni SakiyamaAtsushi ShirakawaYusuke OkadaKasumi SanadaKojiro NakaseKoichiro MandaiAzumi SuzukiAtsuhiro MoritaKiyohito TanakaKoji UnoKenjiro Yasuda

Published in: Journal of gastroenterology and hepatology (2018)

Re-screening with the FIT should not be recommended for at least 5 years for average-risk patients after colonoscopy without high-risk neoplasms, because the risks of colorectal cancer are low in such patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
climate change